tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

382 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$17.48
$1.40B
-33.72
321.20%
7 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$4.39
$949.02M
-33.83
788.66%
9 Buy
0 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$7.55
$502.83M
-9.57
187.62%
6 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$56.08
$375.30M
-35.28
75.96%
7 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.10B
564.93%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GLUE
Monte Rosa Therapeutics
17.48
13.26
314.22%
CTMX
CytomX Therapeutics
4.39
3.86
725.19%
FULC
Fulcrum Therapeutics
7.55
4.86
180.67%
MNPR
Monopar Therapeutics Inc
56.08
21.19
60.73%
OPT
INBX
Inhibrx Biosciences Inc
75.27
63.66
548.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts